Your Article Summary
See Latest ArticlesTreatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice
Rheumatology, 07/01/09
Elewaut D et al. – This review focuses on current progress in treatment options in ankylosing spondylitis (AS) with special emphasis on extra-articular features.
- TNF inhibition has demonstrated effectiveness in the treatment of AS symptoms
- However, the efficacy of anti-TNF agents varies in the treatment of extra-articular manifestations and comorbidities
- Significant reductions in the incidence of flares of uveitis and IBD with infliximab and adalimumab (uveitis only) treatment have been shown, but not with etanercept
- All 3 anti-TNF agents (infliximab, adalimumab, etanercept) have demonstrated efficacy in psoriasis (not associated with AS)
- When evaluating as to which agent to use in the treatment of AS, an important consideration is the overall well-being of the patient
- To date, infliximab appears to be the best studied agent with a wide spectrum of proven efficacy
Related Articles
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 69%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 68%
Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism
Rheumatology International, 11/11/09
Relevance Score: 67%
Concomitant cervical and thoracic spinal fractures in ankylosing spondylitis: A case report and review of literature
Injury Extra, 11/05/09
Relevance Score: 67%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 67%
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population
Scandinavian Journal of Rheumatology , 11/24/09
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene TRADD (TNF receptor type 1-associated death domain)
Annals of Rheumatic Diseases, 11/13/09